Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst & Young Entrepreneur of the Year 2009 Award Finalist in Greater Washington

ROCKVILLE, Md.--(Business Wire)--
Emergent BioSolutions Inc. (NYSE:EBS) announced today that its chairman and
chief executive officer, Mr. Fuad El-Hibri, is a finalist for the Ernst & Young
Entrepreneur of the Year® 2009 Award in the Greater Washington region. According
to Ernst & Young LLP, the awards program recognizes entrepreneurs who
demonstrate extraordinary success in the areas of innovation, financial
performance and personal commitment to their businesses and communities. Mr.
El-Hibri was selected as a finalist from nearly 100 nominations by a panel of
independent judges. Award winners will be announced at a special gala event on
June 18 at the Ritz-Carlton, Tysons Corner in Virginia.

"It is an honor to be chosen as a finalist for the Ernst & Young Entrepreneur of
the Year Award," said Mr. Fuad El-Hibri. "I am proud of the entrepreneurial
spirit, commitment, and collaboration that prevail at Emergent, which are key
factors to our company`s success. This recognition represents the contributions
of each and every member of the Emergent Team as we work together in pursuit of
our company mission - to protect life."

Mr. El-Hibri was also a finalist for the Greater Washington region in 2007. The
Ernst & Young Entrepreneur of the Year awards program celebrates its 23rd
anniversary this year. The program has expanded to recognize business leaders in
over 135 cities in 50 countries throughout the world.

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the
development, manufacture and commercialization of vaccines and therapeutics that
assist the body`s immune system to prevent or treat disease. Emergent`s marketed
product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine licensed by
the U.S. Food and Drug Administration for the prevention of anthrax. Emergent`s
development pipeline includes programs focused on anthrax, botulism,
tuberculosis, typhoid, hepatitis B and chlamydia. Additional information may be
found at www.emergentbiosolutions.com.

About Ernst & Young`s Entrepreneur of the Year® Awards Program

Ernst & Young`s Entrepreneur of the Year® Award is the world`s most prestigious
business award for entrepreneurs. The award makes a difference through the way
it encourages entrepreneurial activity among those with potential and recognizes
the contribution of people who inspire others with their vision, leadership and
achievement. As the first and only truly global award of its kind, the Ernst &
Young Entrepreneur of the Year® award celebrates those who are building and
leading successful, growing and dynamic businesses, recognizing them through
regional, national and global awards programs in more than 135 cities in 50
countries.

Sponsors
Founded and produced by Ernst & Young LLP, the Entrepreneur of the Year awards
are pleased to have the Ewing Marion Kauffman Foundation and SAP America as
national sponsors.

In Greater Washington, sponsors include HSBC Bank, Pillsbury Law, Reznick Group,
Lockton Companies and the Washington Business Journal.

Emergent BioSolutions Inc.
Investors Contact:
Robert G. Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media Contact:
Tracey Schmitt
Vice President, Corporate Communications
301-795-1800
SchmittT@ebsi.com

Copyright Business Wire 2009